Serum alpha-fetoprotein is the standard clinical biomarker for hepatocellular carcinoma. However, a new study from experts at the Cleveland Clinic shows that other emerging biomarkers, such as ...

Among patients with screen-detected HCC, nearly half were identified through imaging studies alone (44.6%) or by both imaging and AFP tests (44.7%). The remaining 10.6% had HCC identified solely ...

If the HCC prevalence rates were more like those seen in most liver clinics, ~5%, the positive predictive value (PPV) of an AFP of 20 ng/mL would be only 41.5%, and even at a cutoff of 400 ng/mL ...

Early detection of hepatocellular carcinoma (HCC) is crucial for improving survival in patients with chronic hepatitis. The GALAD algorithm combines gender (biological sex), age, α-fetoprotein ...

Alpha-fetoprotein Production. A significant difference in serum alpha-fetoprotein (AFP)-production was observed in HCC's associated with underlying HBV as opposed to those associated with HCV ...

Hepatocellular carcinoma is a cancer that starts in your liver. ... Unborn babies have high levels of AFP, but it decreases in most people right after birth.

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. ... The use of ultrasound, along with alpha-fetoprotein (AFP) testing, is common for surveillance.

Early detection of hepatocellular carcinoma (HCC) ... The GALAD algorithm combines gender (biological sex), age, α-fetoprotein (AFP), Lens culinaris agglutinin-reactive fraction of AFP ...

We evaluated standardized protocol-collected data on clinical, ultrasonographic, biochemical, and pathological criteria in a multisite study of 649 suspected HCC cases in Uganda. Participants ...

An AFP-L3 to total AFP ratio more than 10% is suggestive of HCC. Abnormal prothrombin (APT) It’s been used as a tumor marker for diagnosing liver cancer in Japan, Europe, and the United States ...